Your browser doesn't support javascript.
loading
Incidence and Mortality of Parkinson's Disease in Estonia.
Kadastik-Eerme, Liis; Taba, Nele; Asser, Toomas; Taba, Pille.
Afiliação
  • Kadastik-Eerme L; Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
  • Taba N; Department of Neurology and Neurosurgery, Tartu University Hospital, Tartu, Estonia.
  • Asser T; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Taba P; Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
Neuroepidemiology ; 53(1-2): 63-72, 2019.
Article em En | MEDLINE | ID: mdl-30991384
ABSTRACT

BACKGROUND:

There is lack of data on the incidence of Parkinson's disease (PD) based on repeat studies. Mortality rates of PD in Estonia have never been studied before.

OBJECTIVES:

To estimate the incidence and mortality rates of PD in -Estonia, to compare current incidence rates with those of the prior epidemiological study in Estonia, and to examine the reported causes of death of the study population.

METHODS:

Eligible subjects were identified from multiple case-finding sources. Subjects were subsequently tracked on the Electronic-Health Record until either the end of the study, or their death. Incidence rates and standardized mortality ratios (SMR) were calculated. Causes of death were identified, based on the data from death certificates.

RESULTS:

In the current study, the overall age-adjusted incidence rate was 28.0/100,000 person-years (95% CI 25.2-30.8). Compared with the previous study, the age-adjusted incidence rate inEstonia has not significantly changed (rate ratio 1.11; p = 0.19). Overall SMR for the inception cohort of PD cases with a median follow-up time of 5 years was 1.12 (95% CI 0.88-1.36; p = 0.3). For those deceased subjects known to have had clinically diagnosed PD, this was mentioned on 46.8% of death certificates.

CONCLUSIONS:

Over the last 20 years, the overall incidence of PD in Estonia has remained comparatively stable. The data did not show an excess mortality in PD patients (vs. general population) in the first 5 years of the disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Neuroepidemiology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estônia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Neuroepidemiology Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estônia